APH vs PRCT · P/E 40, rev $23.09B vs rev $224.5M
Amphenol Corporation (APH) versus Procept Biorobotics Corp (PRCT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Procept Biorobotics Corp (PRCT) is a medical devices company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported PRCT revenue for 2024-12-31 was $224.5M. Net income was -$91.4M. Revenue was up 64.8% from 2023-12-31 to 2024-12-31. PRCT currently screens at market cap $1.52B.
APH currently screens at market cap $170.77B and trailing P/E 39.9. PRCT currently screens at market cap $1.52B.
Not investment advice. Open the APH and PRCT stock pages for the full models.
Not investment advice.